Ovid Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Ovid Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Ovid Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ovid Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.8k | 2.9k | 1.30 |
| 2025-03-31 | $377k | 1.2M | 0.31 |
| 2024-12-31 | $1.3M | 1.4M | 0.93 |
| 2024-09-30 | $1.7M | 1.5M | 1.18 |
| 2024-06-30 | $1.1M | 1.5M | 0.77 |
| 2024-03-31 | $4.8M | 1.6M | 3.05 |
| 2023-12-31 | $5.3M | 1.6M | 3.22 |
| 2023-09-30 | $6.2M | 1.6M | 3.84 |
| 2023-06-30 | $156k | 48k | 3.28 |
| 2023-03-31 | $5.3k | 1.9k | 2.83 |
| 2022-12-31 | $3.9k | 1.9k | 2.12 |
| 2022-06-30 | $7.0k | 3.0k | 2.30 |
| 2022-03-31 | $25k | 8.0k | 3.11 |
| 2021-12-31 | $20k | 6.1k | 3.27 |
| 2021-03-31 | $72k | 18k | 4.04 |
| 2020-12-31 | $49k | 21k | 2.33 |
| 2020-09-30 | $95k | 16k | 5.95 |
| 2020-06-30 | $179k | 24k | 7.36 |
| 2020-03-31 | $253k | 85k | 2.98 |
| 2019-12-31 | $912k | 220k | 4.15 |
| 2019-09-30 | $316k | 97k | 3.24 |
| 2019-06-30 | $129k | 70k | 1.84 |
| 2019-03-31 | $168k | 94k | 1.78 |
| 2018-12-31 | $320k | 134k | 2.38 |
| 2018-09-30 | $305k | 55k | 5.57 |
| 2018-06-30 | $182k | 23k | 7.85 |
| 2018-03-31 | $227k | 33k | 6.89 |
| 2017-12-31 | $56k | 5.7k | 9.84 |